• Mutual Funds
  • Nippon India Mutual Fund
  • Nippon India Nifty Pharma ETF (G)
Nippon Mutual Fund

Nippon India Nifty Pharma ETF (G)

EquityIndex Funds

23.8434

NAV (Sep 17)

16.636%
Till Date CAGR
Scripbox Opinion
Not Reviewed yet
Our analysis of this fundLearn how we rate funds ->
Scripbox Recommended Equity Funds
Want the equity funds that are right for your long term equity investment needs?Learn more

Investment Calculator

Investment Duration5 years

0

Total Investment

0

Wealth Gained

0

Total Corpus Created (₹)

With CAGR of 11.25 % in 5 years

Historical NAV

23.8434

NAV (Sep 17)

Fund Returns

Last 1Y
50.1%
Last 3Y
18.3%
Last 5Y
NA
Last 10Y
NA
Since Inception
16.6%
6 Month CAGR
25.2%

Scheme Information

Investment Objective

The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors.

Expense Ratio
0.21
Launched (0y ago)
0.21
AUM in Crores
798.6
ISIN
INF204KC1089
Lock-in
Benchmark
NIFTY Pharma Total Return Index
SIP Minimum
1000
Lumpsum Min.
5000
Standard Deviation (3yr)
Standard Deviation
16.3
Beta
1
Sharpe Ratio
0.8
YTM
Fund Managers

Himanshu Mange

Fund Manager

Important Links

Scheme Information Document

Statement of Additional Information

Portfolio Disclosure

Returns Calculator Comparison

of

for

with step up of

AssetReturnsTotal CorpusGainsCAGR
Nippon India Nifty Pharma ETF (G)70%11,61,112 4,28,50018.3%
EPF70% 9,00,761 1,68,1498.50%
Property70% 8,67,662 1,35,0507.00%
PPF70% 8,69,819 1,37,2077.10%
Bank FD70% 8,46,471 1,13,8596.00%
Gold70% 8,46,471 1,13,8596.00%
Savings Bank70% 8,25,950 93,3385.00%

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.

Asset allocation and Holdings

Last updated on 2024-09-11

Top Stock Holdings

Sun Pharmaceutical Industries Ltd.

24.6%
24.62%

Dr. Reddy's Laboratories Ltd.

10.9%
10.9%

Cipla Ltd.

10.8%
10.75%

Divi's Laboratories Ltd.

8.3%
8.32%

Lupin Ltd.

6.1%
6.13%
See all holdings

Allocation by Sector

Healthcare

99.9%
99.9%
See all sectors

Comparison with Equity Funds

Fund NameFund Size
mirae-asset-global
Mirae Asset ELSS Tax Saver Fund (G)

₹ 26,041 cr

₹ 23,712 cr

₹ 64,222 cr

₹ 50,154 cr

₹ 17,488 cr

amc-img

About the AMC

Nippon India Mutual Fund

Reliance Nippon India Mutual Fund was established in 1996. It is a joint venture between India's Reliance Mutual Fund and Japan's Nippon Life Insurance Company. It is india's top asset management company with a total AUM of Rs 1.8 Lac Crore with about 91.9 lac active folios. It is the first compnay to be listed and traded on both the NSE and Bombay Stock Exchange (BSE).amc-img
Fund NameScripbox Opinion
Till Date CAGR

5.901%

6.864%

6.568%

8.931%

17.933%

21.08%

21.978%

13.718%

14.951%

8.07%

Nippon India Nifty Pharma ETF (G) Review

Nippon India Nifty Pharma ETF (G) is a Equity Equity fund and has delivered an annualised return of 16.636% over a period of 3 years. The fund is managed by Nippon India Mutual Fund. The fund manager’s name is [object Object].

Nav of Nippon India Nifty Pharma ETF (G) as of 9/17/2024 is ₹23.84 with the total AUM as of 9/18/2024 is ₹798.6066. With Scripbox you can compare and check the latest nav for all mutual funds in India. Nippon India Nifty Pharma ETF (G) was launched on 2021-07-02. The category risk of the fund is null.

The minimum SIP amount for Nippon India Nifty Pharma ETF (G) is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.

Nippon India Nifty Pharma ETF (G) is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to NIFTY Pharma Total Return Index.

Nippon India Nifty Pharma ETF (G) is rated as a null fund in Equity and delivered 50.125% returns in the last 1 year. Scripbox provides a compare mutual funds research tool to view a detailed comparison with Nippon India Nifty Pharma ETF (G).

Frequently Asked Questions

What is Nippon India Nifty Pharma ETF (G)?

Nippon India Nifty Pharma ETF (G) is a Equity Equity scheme predominantly investing across Equity instruments with an investment objective to generate wealth over the long term.

How to invest in Nippon India Nifty Pharma ETF (G)?

You can invest in Nippon India Nifty Pharma ETF (G) through AMC, intermediaries, brokers or platforms like Scripbox. To learn step by step process visit how to invest in mutual funds?

What is the minimum sip amount of Nippon India Nifty Pharma ETF (G)?

The minimum sip amount for Nippon India Nifty Pharma ETF (G) is ₹1000. You can invest in multiples of ₹5000.

Is Nippon India Nifty Pharma ETF (G) good to invest in?

As per Scripbox experts, Nippon India Nifty Pharma ETF (G) is a fund. You can investNippon India Nifty Pharma ETF (G) fund if its investment objective and risk-o-meter matches your investment goals and risk preferences.

What is the expense ratio of the Nippon India Nifty Pharma ETF (G)?

The expense ratio of the Nippon India Nifty Pharma ETF (G) is 0.21% for regular plan.